13 noviembre 2019

ZEPSYRE® Clinical Trial is Showing Promising Results for Mesothelioma Patients .

2 Links :

*.- Zepsyre® en Monoterapia es Activo en Mesothelioma Pleural Maligno .

*.- What Is Pleural Mesothelioma?.


Pleural mesothelioma is a rare malignant cancer. Almost 75% of diagnosed mesothelioma cases form in the pleura, making it the most common of the four types.
The cause of pleural mesothelioma is exposure to asbestos fibers, which are inhaled into the lungs. It usually takes from 20 to 50 years for mesothelioma to develop after a person’s first exposure to asbestos. Because of this latency period, the disease usually affects people older than 75.
The average life expectancy for pleural mesothelioma is often less than 18 months, but it depends on many factors.
Although there is no cure for mesothelioma, some patients live much longer with treatments. Combining several treatments, such as surgery, chemotherapy and radiation therapy, has helped some people live for years. Clinical trials offer access to new treatments such as immunotherapy.
Where pleural mesothelioma forms

Pleural Mesothelioma Facts

  • Most common type of mesothelioma
  • Forms on soft tissue covering the lungs
  • Symptoms: Shortness of breath, chest pain, dry cough and fatigue
  • Diagnostic Tools: Imaging scans and tissue biopsies
  • Treatments: Chemotherapy, surgery, radiation therapy, immunotherapy and experimental therapies
  • Life Expectancy: About 40 percent live at least one year
...